文献速递脊柱关节炎

银屑病关节炎患者可接受症状状态与疾病活动度的关系

The relationship between patient acceptable symptom state and disease activity in patients with psoriatic arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

本研究纳入229例银屑病关节炎患者,用ROC曲线确定PASDAS和DAPSA与患者可接受症状状态(PASS)一致的切点,并分析各疾病活动度阈值下PASS报告频率。结果显示PASDAS的PASS切点为3.79,DAPSA为11.10,且PASDAS低疾病活动度与DAPSA低疾病活动度或缓解目标与PASS吻合良好。

要点

  • PASDAS的PASS切点为3.79,DAPSA的PASS切点为11.10。
  • PASDAS低疾病活动度者90%认为症状可接受,中、高活动度分别为55%和17%。
  • DAPSA缓解者98%认为症状可接受,低、中、高活动度分别为85%、22%和18%。

核心结论

  • 本研究定义了PASDAS和DAPSA的PASS切点,PASDAS低疾病活动度目标及DAPSA低疾病活动度或缓解目标与PASS吻合良好。

研究设计与样本

  • 前瞻性研究,采用标准方案记录医师评估和患者报告结局以计算PASDAS和DAPSA,用ROC曲线分析确定PASS阈值。
  • 共纳入229例银屑病关节炎患者,男性58.5%,平均年龄55.5岁,平均病程17.1年。

主要发现

  • PASDAS的PASS阈值为3.79(AUC 0.86,敏感度0.75,特异度0.82)。
  • DAPSA的PASS阈值为11.10(AUC 0.91,敏感度0.89,特异度0.82)。
  • PASDAS低疾病活动度患者中90%认为症状可接受,中疾病活动度为55%,高疾病活动度为17%。
  • DAPSA缓解患者中98%认为症状可接受,低疾病活动度为85%,中疾病活动度为22%,高疾病活动度为18%。

关键数值与推荐

  • PASDAS的PASS切点为3.79,DAPSA的PASS切点为11.10。
  • PASDAS低疾病活动度阈值和DAPSA低疾病活动度或缓解阈值与PASS一致。

临床怎么用

  • 临床中可将PASDAS≤3.79或DAPSA≤11.10作为患者症状可接受的参考切点。
  • PASDAS低疾病活动度和DAPSA低疾病活动度或缓解可作为与患者可接受症状状态对齐的治疗目标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The Psoriatic Arthritis Disease Activity Score (PASDAS) and Disease Activity Index for Psoriatic Arthritis (DAPSA) are composite PsA disease activity measures. We sought to identify the PASDAS and DAPSA cut-off points consistent with patient acceptable symptom state (PASS), the threshold of symptoms beyond which patients consider themselves well, and examine PASS across published PASDAS and DAPSA thresholds for low, moderate and high disease activity. METHODS: We used a standard protocol including physician assessment and patient-reported outcomes to prospectively record measures required to calculate PASDAS and DAPSA. We identified PASS thresholds for the PASDAS and DAPSA using receiver operating characteristics curve analyses. We assessed the frequency of reporting acceptable symptom state across disease activity thresholds for PASDAS and DAPSA scores. RESULTS: A total of 229 patients (58.5% male, mean age 55.5 years, mean disease duration 17.1 years) were recruited. The PASS threshold for the PASDAS was 3.79 [area under the curve (AUC) 0.86, sensitivity 0.75, specificity 0.82] and for the DAPSA was 11.10 (AUC 0.91, sensitivity 0.89, specificity 0.82). With the PASDAS, 90% of patients defined as having low disease activity considered their symptom state acceptable, compared with 55% and 17% among those with moderate and high disease activity, respectively. With the DAPSA, 98% of patients in disease remission considered their symptom state acceptable compared with 85, 22 and 18% among those with low, moderate and high disease activity, respectively. CONCLUSION: We have defined PASS thresholds for PASDAS and DAPSA. The PASDAS target for low disease activity and DAPSA targets of low disease activity or remission align well with PASS.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Fei JZ, Perruccio AV, Ye JY, et al. The relationship between patient acceptable symptom state and disease activity in patients with psoriatic arthritis. Rheumatology (Oxford). 2020. PMID: 31199486. doi:10.1093/rheumatology/kez202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。